Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)

Abroad (travel likely)RecruitingPHASE2

Conditions

Generalized Pustular Psoriasis (GPP)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University People's Hospital (PKUPH), Beijing, China
Contact: Study coordinator (Jianzhong Zhang, Phd)
Shanghai Huaota Biopharmaceutical Co., Ltd, Shanghai, China
Contact: Study coordinator (zhou guodong) · guodong.zhou@huaota.com · +86 13636638684

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis

Generalized Pustular Psoriasis

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Beijing, China

Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis

Generalized Pustular Psoriasis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Beijing, China · Beijing, China

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Generalized Pustular Psoriasis

Abroad (travel likely)Recruiting

Waltham, United States

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

Palmoplantar Pustulosis

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Coral Gables, United States